tdrago, good observation. Bloomberg and Thomson/Reuters usually...

tdrago, good observation.
Bloomberg and Thomson/Reuters usually have a fuller list of analysts than Morningstar, so let's look at Thomson/Reuters consensus which is based on 6 brokers:

FY15 NPAT
Consensus =$61.2M (consensus was $60.8M back in Dec14)
Estimated actual = $69.2M (based on 2x 1H15 actual of $34.6M)*
*AGI guidance is that 2H15 will be better than 1H15 for reasons stated in report.

FY15 EPS
Consensus=19.4 cps
Estimated actual =22 cps (based on 2x 1H15 actual of 11 cps)*

These results look VERY good. But remember that AGI set lower guidance in Aug14, which had the effect of slashing the sp. Before lowering guidance in Aug14, FY15 consensus NPAT was $70M. So AGI might yet achieve the consensus that it later obliterated. Time will tell. But the real boost with come after the US production line gets built (still some time away).

longorshort -- you're a classic chump for confirmation bias, aren't you. Or just ramping? AGI's overseas sales have been jumping, and in those regions AGI is also competing with the other vendors that you prefer. Also, your explanation for poor 1H15 sales in OZ is a not-so subtle statement that management is lying. Unlikely they are. You might have useful information/critique in your post, but it got lost in the credibility fail. Use more evidence to back your arguments, and preferably add some balanced analysis.